Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage

References

• Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media: systematic review and global estimates. Plos One. 2012;7(4):e36226.
   PubMed Web of Science ®Google Scholar
• Synflorix Summary of Product Characteristics (Sri Lanka) [Internet]; [cited 2016 Jun]. Available from: https://health.gsk.lk/content/dam/global/Health/en_lk/PI/pdf/S/Synflorix-IPI14-24.02.2015.pdf
   Google Scholar
• Synflorix Summary of Product Characteristics (India) [Internet]; [cited 2016 Jun]. Available from: http://www.cdsco.nic.in/SMPC/GSK_Synflorix%20PI_Version%20SYN_PI_IN_2011_01%20dated%2026%20April%202011.pdf
   Google Scholar
• Souter J. An update on pneumococcal vaccination in children and adults. S Afr Pharm J. 2014;81(2):15–18.
   Google Scholar
• Murphy TF, Faden H, Bakaletz LO, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28(1):43–48.
   PubMed Web of Science ®Google Scholar
• Van Eldere J, Slack MP, Ladhani S, et al. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis. 2014;14(12):1281–1292.
   PubMed Web of Science ®Google Scholar
• WHO. Haemophilus influenzae type b (Hib) vaccination position paper - July 2013. Wkly Epidemiol Rec. 2013;88(39):413–426.
   PubMedGoogle Scholar
• Gessner BD, Adegbola RA. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines. Vaccine. 2008;26(Suppl 2):B3–8.
   PubMed Web of Science ®Google Scholar
• Pizzutto SJ, Yerkovich ST, Upham JW, et al. Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae. Plos One. 2014;9(8):e104236.
   PubMed Web of Science ®Google Scholar
• Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57(9):759–764.
   PubMed Web of Science ®Google Scholar
• Alikhan MM, Lee FE. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2014;20(2):159–164.
   PubMed Web of Science ®Google Scholar
• Rubach MP, Bender JM, Mottice S, et al. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis. 2011;17(9):1645–1650.
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J. 2004;23(12):1142–1152.
   PubMed Web of Science ®Google Scholar
• Venekamp RP, Sanders SL, Glasziou PP, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2015;6:CD000219.
   Google Scholar
• Kvaerner KJ, Nafstad P, Hagen JA, et al. Recurrent acute otitis media: the significance of age at onset. Acta Otolaryngol. 1997;117(4):578–584.
   PubMed Web of Science ®Google Scholar
• Palmu AA, Verho J, Jokinen J, et al. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J. 2004;23(8):732–738.
   PubMed Web of Science ®Google Scholar
• Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J. 2000;19(5 Suppl):S37–46.
   PubMed Web of Science ®Google Scholar
• Acute otitis media [Internet]; [cited 2016 Jul]. Available from: http://emedicine.medscape.com/article/859316-overview#a5
   Google Scholar
• Kaur R, Chang A, Xu Q, et al. Phylogenetic relatedness and diversity of non-typable Haemophilus influenzae in the nasopharynx and middle ear fluid of children with acute otitis media. J Med Microbiol. 2011;60(Pt 12):1841–1848.
   PubMed Web of Science ®Google Scholar
• Van Dongen TM, Van Der Heijden GJ, Van Zon A, et al. Evaluation of concordance between the microorganisms detected in the nasopharynx and middle ear of children with otitis media. Pediatr Infect Dis J. 2013;32(5):549–552.
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Satran R, Piglansky L, et al. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J. 2003;22(6):509–515.
   PubMed Web of Science ®Google Scholar
• Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23(9):824–828.
   PubMed Web of Science ®Google Scholar
• Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. Jama. 2010;304(19):2161–2169.
   PubMed Web of Science ®Google Scholar
• Bardach A, Ciapponi A, Garcia-Marti S, et al. Epidemiology of acute otitis media in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol. 2011;75(9):1062–1070.
   PubMed Web of Science ®Google Scholar
• Smith-Vaughan HC, Binks MJ, Marsh RL, et al. Dominance of Haemophilus influenzae in ear discharge from Indigenous Australian children with acute otitis media with tympanic membrane perforation. BMC Ear Nose Throat Disord. 2013;13(1):12.
   PubMedGoogle Scholar
• Hallstrom T, Riesbeck K. Haemophilus influenzae and the complement system. Trends Microbiol. 2010;18(6):258–265.
   PubMed Web of Science ®Google Scholar
• Starner TD, Swords WE, Apicella MA, et al. Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation. Infect Immun. 2002;70(9):5287–5289.
   PubMed Web of Science ®Google Scholar
• Rao VK, Krasan GP, Hendrixson DR, et al. Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev. 1999;23(2):99–129.
   PubMed Web of Science ®Google Scholar
• Erwin AL, Smith AL. Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol. 2007;15(8):355–362.
   PubMed Web of Science ®Google Scholar
• Morey P, Cano V, Marti-Lliteras P, et al. Evidence for a non-replicative intracellular stage of nontypable Haemophilus influenzae in epithelial cells. Microbiology. 2011;157(Pt 1):234–250.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Kirkham C. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol. 2002;2:7.
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. Jama. 2006;296(2):202–211.
   PubMed Web of Science ®Google Scholar
• Smith HK, Nelson KL, Calaunan ES, et al. Affect of anaerobiosis on the antibiotic susceptibility of H. influenzae. BMC Res Notes. 2013;6:241.
   PubMedGoogle Scholar
• Cavaliere R, Ball JL, Turnbull L, et al. The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeable Hemophilus influenzae biofilms to treatment with ampicillin and ciprofloxacin. Microbiologyopen. 2014;3(4):557–567.
   PubMed Web of Science ®Google Scholar
• Izano EA, Shah SM, Kaplan JB. Intercellular adhesion and biocide resistance in nontypeable Haemophilus influenzae biofilms. Microb Pathog. 2009;46(4):207–213.
   PubMed Web of Science ®Google Scholar
• Schweda EK, Richards JC, Hood DW, et al. Expression and structural diversity of the lipopolysaccharide of Haemophilus influenzae: implication in virulence. Int J Med Microbiol. 2007;297(5):297–306.
   PubMed Web of Science ®Google Scholar
• Garmendia J, Marti-Lliteras P, Moleres J, et al. Genotypic and phenotypic diversity of the noncapsulated Haemophilus influenzae: adaptation and pathogenesis in the human airways. Int Microbiol. 2012;15(4):159–172.
   PubMed Web of Science ®Google Scholar
• Fernaays MM, Lesse AJ, Sethi S, et al. Differential genome contents of nontypeable Haemophilus influenzae strains from adults with chronic obstructive pulmonary disease. Infect Immun. 2006;74(6):3366–3374.
   PubMed Web of Science ®Google Scholar
• Hoppe HL, Johnson CE. Otitis media: focus on antimicrobial resistance and new treatment options. Am J Health Syst Pharm. 1998;55(18):1881-1897; quiz 1932-1883.
   PubMed Web of Science ®Google Scholar
• Giebink GS. Preventing otitis media. Ann Otol Rhinol Laryngol Suppl. 1994;163:20–23.
   PubMedGoogle Scholar
• Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344(6):403–409.
   PubMed Web of Science ®Google Scholar
• Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23(9):829–833.
   PubMed Web of Science ®Google Scholar
• Abdelnour A, Arguedas A, Dagan R, et al. Etiology and antimicrobial susceptibility of middle ear fluid pathogens in Costa Rican children with otitis media before and after the introduction of the 7-valent pneumococcal conjugate vaccine in the National Immunization Program: acute otitis media microbiology in Costa Rican children. Medicine. 2015;94(2):e320.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, et al. Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media. Clin Infect Dis. 2016;63(5):611–618.
   PubMed Web of Science ®Google Scholar
• Stamboulidis K, Chatzaki D, Poulakou G, et al. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J. 2011;30(7):551–555.
   PubMed Web of Science ®Google Scholar
• Dagan R, Pelton S, Bakaletz L, et al. Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis. 2016;16(4):480–492.
   PubMed Web of Science ®Google Scholar
• Jokinen J, Palmu AA, Kilpi T. Acute otitis media replacement and recurrence in the Finnish otitis media vaccine trial. Clin Infect Dis. 2012;55(12):1673–1676.
   PubMed Web of Science ®Google Scholar
• Akkoyunlu M, Ruan M, Forsgren A. Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun. 1991;59(4):1231–1238.
   PubMed Web of Science ®Google Scholar
• Janson H, Melhus A, Hermansson A, et al. Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model. Infect Immun. 1994;62(11):4848–4854.
   PubMed Web of Science ®Google Scholar
• Munson RS Jr., Sasaki K. Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase. J Bacteriol. 1993;175(14):4569–4571.
   PubMed Web of Science ®Google Scholar
• Janson H, Ruan M, Forsgren A. Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains. Infect Immun. 1993;61(11):4546–4552.
   PubMed Web of Science ®Google Scholar
• Weiser JN, Shchepetov M, Chong ST. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect Immun. 1997;65(3):943–950.
   PubMed Web of Science ®Google Scholar
• Fox KL, Li J, Schweda EK, et al. Duplicate copies of lic1 direct the addition of multiple phosphocholine residues in the lipopolysaccharide of Haemophilus influenzae. Infect Immun. 2008;76(2):588–600.
   PubMed Web of Science ®Google Scholar
• Swords WE, Buscher BA, Ver Steeg Ii K, et al. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol. 2000;37(1):13–27.
   PubMed Web of Science ®Google Scholar
• Swords WE, Ketterer MR, Shao J, et al. Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell Microbiol. 2001;3(8):525–536.
   PubMed Web of Science ®Google Scholar
• Johnson RW, McGillivary G, Denoel P, et al. Abrogation of nontypeable Haemophilus influenzae protein D function reduces phosphorylcholine decoration, adherence to airway epithelial cells, and fitness in a chinchilla model of otitis media. Vaccine. 2011;29(6):1211–1221.
   PubMed Web of Science ®Google Scholar
• Akkoyunlu M, Forsgren A. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats. Apmis. 1996;104(10):709–717.
   PubMed Web of Science ®Google Scholar
• Akkoyunlu M, Janson H, Ruan M, et al. Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae. Infect Immun. 1996;64(11):4586–4592.
   PubMed Web of Science ®Google Scholar
• Poolman JT, Bakaletz L, Cripps A, et al. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine. 2000;19(Suppl 1):S108–115.
   PubMed Web of Science ®Google Scholar
• Bakaletz LO, Kennedy BJ, Novotny LA, et al. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect Immun. 1999;67(6):2746–2762.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Kaur R, Casey JR, et al. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2010;28(44):7184–7192.
   PubMed Web of Science ®Google Scholar
• Khan MN, Kaur R, Pichichero ME. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children. FEMS Immunol Med Microbiol. 2012;65(3):439–447.
   PubMedGoogle Scholar
• Wiertsema SP, Corscadden KJ, Mowe EN, et al. IgG responses to pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media. Plos One. 2012;7(11):e49061.
   PubMed Web of Science ®Google Scholar
• Dagan R, Goldblatt D, Maleckar JR, et al. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components. Infect Immun. 2004;72(9):5383–5391.
   PubMed Web of Science ®Google Scholar
• Novotny LA, Jurcisek JA, Godfroid F, et al. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae. Vaccine. 2006;24(22):4804–4811.
   PubMed Web of Science ®Google Scholar
• Bakaletz LO. Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention. Expert Rev Vaccines. 2009;8(8):1063–1082.
   PubMed Web of Science ®Google Scholar
• Prymula R, Kriz P, Kaliskova E, et al. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine. 2009;28(1):71–78.
   PubMed Web of Science ®Google Scholar
• Prymula R, Chlibek R, Splino M, et al. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. Vaccine. 2008;26(35):4563–4570.
   PubMed Web of Science ®Google Scholar
• Nurkka A, Joensuu J, Henckaerts I, et al. Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants. Pediatr Infect Dis J. 2004;23(11):1008–1014.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Wysocki J, Chevallier B, et al. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J. 2009;28(4 Suppl):S66–76.
   PubMed Web of Science ®Google Scholar
• Silfverdal SA, Coremans V, Francois N, et al. Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Expert Rev Vaccines. 2016;16:1–13.
   Web of Science ®Google Scholar
• Tregnaghi MW, Saez-Llorens X, Lopez P, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. Plos Med. 2014;11(6):e1001657.
   PubMed Web of Science ®Google Scholar
• Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367(9512):740–748.
   PubMed Web of Science ®Google Scholar
• Prymula R, Hanovcova I, Splino M, et al. Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine. 2011;29(10):1959–1967.
   PubMed Web of Science ®Google Scholar
• Van Den Bergh MR, Spijkerman J, Swinnen KM, et al. Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis. 2013;56(3):e30–39.
   PubMed Web of Science ®Google Scholar
• Hammitt LL, Ojal J, Bashraheil M, et al. Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial. Plos One. 2014;9(1):e85459.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Forsten A, Seppa I, et al. Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland. J Pediatric Infect Dis Soc. 2016;5(3):237–248.
   PubMed Web of Science ®Google Scholar
• CDC. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998–2003. MMWR Morb Mortal Wkly Rep. 2005;54(36):893–897.
   PubMedGoogle Scholar
• Resman F, Ristovski M, Ahl J, et al. Invasive disease caused by Haemophilus influenzae in Sweden 1997–2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect. 2011;17(11):1638–1645.
   PubMed Web of Science ®Google Scholar
• Sáez-Llorens X, Rowley S, Wong D, et al. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children – a randomized controlled trial. Hum Vaccin Immunother. 2017. doi: 10.1080/21645515.2017.1287640. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Palmu AA, Jokinen J, Borys D, et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet. 2013;381(9862):214–222.
   PubMed Web of Science ®Google Scholar
• Jokinen J, Kilpi TM, Kaijalainen T, et al. Indirect effectiveness of pneumococcal Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV10) against oropharyngeal and nasopharyngeal carriage - FinIP Indirect Carriage Study. In: 9th international symposium on pneumococci and pneumococcal diseases. Hyderabad, India. ISPPD-9. Abstract number [ISPPD-0395], pneumonia, volume 3, 2014.
   Google Scholar
• Leach AJ, Wigger C, Andrews R, et al. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC Pediatr. 2014;14:200.
   PubMed Web of Science ®Google Scholar
• Leach AJ, Wigger C, Hare K, et al. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. BMC Pediatr. 2015;15:162.
   PubMed Web of Science ®Google Scholar
• Kilpi T, Ahman H, Jokinen J, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis. 2003;37(9):1155–1164.
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Yothers G, Dagan R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002;21(11):1008–1016.
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Kristinsson KG, Erlendsdottir H, et al. Decreased incidence of respiratory infections in children after vaccination with ten-valent pneumococcal vaccine. Pediatr Infect Dis J. 2015;34(12):1385–1390.
   PubMed Web of Science ®Google Scholar
• Petousis-Harris H, Radke S, Griffin J, et al. Impact of conjugate pneumococcal vaccines on otitis media related hospitalisations in New Zealand. In: 68th annual general and scientific meeting of the New Zealand society of otolaryngology, head and neck surgery (ORL2015). New Zealand; 2015. Available from: https://www.eiseverywhere.com/ereg/popups/custompopup.php?popupid=54483
   Google Scholar
• Hammitt LL, Akech DO, Morpeth SC, et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health. 2014;2(7):e397–405.
   PubMed Web of Science ®Google Scholar
• Bosch AATM, Veenhoven RH, Bruin JP, et al. Return to pre-PCV carriage levels of Staphylococcus aureus 6.5 years after pneumococcal conjugate vaccine in the Dutch national immunization program. Pneumonia. 2014;3:11.
   Google Scholar
• Leach A, Wigger C, Smith-Vaughan HC, et al. Carriage of pneumococcus and non-typeable Haemophilus influenzae in children vaccinated with either 7-valent or 10-valent pneumococcal conjugate vaccines. Pneumonia. 2014;3:37.
   Google Scholar
• Pizzutto SJ, Yerkovich ST, Upham JW, et al. Improving immunity to Haemophilus influenzae in children with chronic suppurative lung disease. Vaccine. 2015;33(2):321–326.
   PubMed Web of Science ®Google Scholar
• O’Grady KA, Grimwood K, Cripps A, et al. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials. 2013;14:282.
   PubMed Web of Science ®Google Scholar
• Binks MJ, Temple B, Kirkham LA, et al. Molecular surveillance of true nontypeable Haemophilus influenzae: an evaluation of PCR screening assays. Plos One. 2012;7(3):e34083.
   PubMed Web of Science ®Google Scholar
• Smith-Vaughan HC, Chang AB, Sarovich DS, et al. Absence of an important vaccine and diagnostic target in carriage- and disease-related nontypeable Haemophilus influenzae. Clin Vaccine Immunol. 2014;21(2):250–252.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Brauer AL, Sethi S, et al. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae. J Infect Dis. 2007;195(1):81–89.
   PubMed Web of Science ®Google Scholar